# VQ Biomedical, Inc. — Form D

VQ Biomedical, Inc. of APEX, NC, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-27. The offering totals $1.6M, of which $1.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-03-27
- Form: D
- Accession: 0002062029-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $1.6M
- Investors: 21
- Date of first sale: 2024-07-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-542278

## Issuer

- Name: VQ Biomedical, Inc.
- CIK: 0002062029
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 5448 APEX PEAKWAY, APEX, NC, 27502
- Phone: 9194463315

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| MARC DESHUSSES | Director | APEX, NC |
| Daniel E Estay | Director | APEX, NC |
| JOE KNIGHT | Director | APEX, NC |
| GALEN ROBERTSON | Director | APEX, NC |
| TOBIAS STRAUBE | Director | APEX, NC |
| GALEN ROBERTSON | Executive Officer | APEX, NC |
| TOBIAS STRAUBE | Executive Officer | APEX, NC |

## More

- [CIK 2062029 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2062029&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002062029-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.